Regencell Bioscience Limited

RGC | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.23

+$0.31 (+5.24%)

At close: Sep 22, 2026, 4:00 PM ET

$6.23

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.93B

Enterprise Value $2.93B

Beta 1.43

Average Volume 254.22K

Shares Outstanding (Diluted) 494.49M

Shares Change YoY 0.01%

Institutional Ownership 0.13%

Exchange NASDAQ

ISIN KYG7487R1002

Price Performance

Price Change 1M 11.3%

Price Change 3M -46.6%

Price Change 6M -75.5%

Price Change YTD -71.2%

Price Change 1Y -61.7%

Price Change 3Y 1438.7%

Price Change 5Y 1187.0%

1M CAGR (ann.) 9.4%

1Y CAGR (ann.) -60.9%

5Y CAGR (ann.) 54.9%

All-Time CAGR 80.6%

Valuation

PE Ratio -416.90

Forward PE N/A

PEG Ratio 4.30

Forward PEG 4.30

PS Ratio N/A

Forward PS N/A

PB Ratio 2,405.48

P/FCF Ratio N/A

P/Adj. FCF Ratio -11,981,561.54

P/OCF Ratio -592.00

EV/Sales N/A

EV/EBIT -414.54

EV/EBITDA -416.95

EV/FCF N/A

Earnings Yield -0.2%

FCF Yield 0.0%

Adj. FCF Yield 0.0%

Financial Health

Net Cash $2.1M

Total Debt $386.3K

Cash & Short-Term Investments $2.36M

Total Assets $3.01M

Current Ratio 1.42

Quick Ratio 1.42

Debt / Equity Ratio 0.32

Debt / EBITDA -0.05

Debt / FCF N/A

OCF / Debt 0.00

Interest Coverage 0.00

Altman Z-Score 959.36

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -233.9%

Return on Equity -231.9%

Return on Invested Capital -444.2%

Return on Capital Employed -529.3%

Return on Tangible Assets -233.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -37.9%

EPS CAGR 5Y -2.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y 21.1%

FCF CAGR 5Y -7.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Oct 27, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $0

Free Cash Flow $0

Adj. Free Cash Flow $-244.81

FCF Per Share -$0.01

OCF Per Share -$0.01

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-40.84K

Operating Income $-7.13M

EBITDA $-7.03M

Net Income $-7.05M

EPS (Diluted) -$0.01

Revenue / Employee N/A

Profit / Employee $-704.86K

Employees 10